Leash Bio Revenue and Competitors

Location

$9M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Leash Bio's estimated annual revenue is currently $2.6M per year.(i)
  • Leash Bio's estimated revenue per employee is $155,000
  • Leash Bio's total funding is $9M.

Employee Data

  • Leash Bio has 17 Employees.(i)
  • Leash Bio grew their employee count by 70% last year.

Leash Bio's People

NameTitleEmail/Phone
1
Co-Founder, CEOReveal Email/Phone
2
CTO and co-founderReveal Email/Phone
3
Head BD and StrategyReveal Email/Phone
4
Head OperationsReveal Email/Phone
5
Senior Director Small Molecule DiscoveryReveal Email/Phone
6
Associate Director, Medicinal ChemistryReveal Email/Phone
7
ScientistReveal Email/Phone
8
Senior Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$2.8M1864%$25.1MN/A
#3
$1.4M90%N/AN/A
#4
$7.1M4639%N/AN/A
#5
$1.4M9-50%N/AN/A
#6
$1.4M9-10%N/AN/A
#7
$25.9M16711%N/AN/A
#8
$1.6M40-48%$17.8MN/A
#9
$3.4M2283%N/AN/A
#10
$2M130%N/AN/A
Add Company

What Is Leash Bio?

Every single machine learning (ML)-driven breakthrough, from language translation to Go championships, was immediately preceded not by an algorithmic innovation but by a massive, well-controlled, purpose-built dataset. An ML-driven breakthrough in medicinal chemistry is going to require a similar dataset, but such high-quality, well-structured experimental data doesn’t exist yet. We're building that data set by making physical measurements of lots of targets (with automated in-house protein production) screened against lots of compounds (with DNA-encoded chemical libraries). We're also building the ML models, that will eventually be generalizable across any protein and novel medicines using insights from our models.

keywords:N/A

$9M

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

70%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.3M17-94%N/A
#2
$1.3M170%N/A
#3
$1.5M17-19%N/A
#4
$0.9M17-23%$9M
#5
$1.5M1721%N/A